Mosley Wealth Management’s Gilead Sciences GILD Stock Holding History

Mosley Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$103K	Sell	814 -3,673	-82%	-$484K	0.03%	198
2026 Q1	$498K	Buy	4,487 +14	+0.3%	+$1.96K	0.23%	94
2025 Q4	$529K	Buy	+4,473	New	+$544K	0.24%	95
2024 Q4	$552K	Buy	5,772 +319	+6%	+$28.7K	0.34%	69
2024 Q3	$471K	Buy	5,453 +559	+11%	+$42.7K	0.32%	72
2024 Q2	$336K	Buy	4,894 +1,006	+26%	+$67.1K	0.29%	74
2024 Q1	$285K	Sell	3,888 -21	-0.5%	-$1.61K	0.27%	82
2023 Q4	$317K	Buy	+3,909	New	+$304K	0.31%	71

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Mosley Wealth Management's GILD Position: Q2 2026 in Review

Mosley Wealth Management reduced its Gilead Sciences (GILD) stake by 82% in Q2 2026, selling an estimated $484K and leaving 814 shares worth $103K. The position accounts for 0.03% of the portfolio, ranked #198.

Mosley Wealth Management first reported a position in GILD in Q4 2023 and has held it in 8 quarters since. The position peaked at $552K in Q4 2024. 1,412 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Mosley Wealth Management held 814 shares of Gilead Sciences worth $103K as of Q2 2026.
Mosley Wealth Management sold 3,673 Gilead Sciences shares in Q2 2026, an estimated $484K.
Gilead Sciences made up 0.03% of Mosley Wealth Management's portfolio in Q2 2026, its #198 holding.
Mosley Wealth Management first reported a position in Gilead Sciences in Q4 2023 and has held it in 8 quarters since.
Mosley Wealth Management's Gilead Sciences position peaked at $552K in Q4 2024.
1,412 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Mosley Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.